第二章 从批判DSM的生态模型获取精神障碍诊断中的概念化能力 （12）
作者的反思性声明
由于本章讨论的许多批评意见观点鲜明且直白，作者的社会地位和意图必然牵涉其中。因此，作为本章作者，进行结构分析时，我们必须审视自己的承诺和利益相关。我们都在心理健康领域进行专业活动，我们对临床心理学和精神医学所掌握的社会和政治权力的看法不可避免地受到这项事业的影响。这种对DSM全方位的批评符合当下日益壮大的一场运动的目的，这场运动正挑战着对人类经验的牢固的生物学理解的支配权，并呼吁在社会、心理、文化、精神和生物的复杂性方面以多样化的模式来理解和支持人类。我们认为，包括DSM在内的主导诊断范式本身就是更广泛的科学、概念和社会问题的一个症状，包括牺牲边缘化的社会成员的问题（见[146]）。我们相信，正如克里斯（Kriss）[109]对手册的批判性评论一样，DSM好像是一部反乌托邦小说一样，对它所创造的社会性疾病具有“循环效应”[76]。或者正如克里斯所说：
小说的设定不是一个物理图景，而是一个概念性的图景。[…]场景[…]是人类深沉的视野之一；我们在一个空旷的田野中徘徊，被盲目和机械的力量所削弱，这些力量的运作完全不可思议。[…]当你阅读时，你慢慢意识到这本书真正的迷恋对象不是书中描述的各种疾病，而是他们的部署中固有的疾病。[…]对于大部分小说来说，这个故事的叙述者所描述的是它自己的孤独，它自己无法欣赏别人，以及它自己对死亡的强烈渴望-但真正的恐怖在于世界上可能产生这样的恐怖。
附本章参考文献195份
References
1. Adame AL, Knudson RM. Beyond the counter-narrative: exploring alternative narratives of recovery from the psychiatric survivor movement. Narrat Inq. 2007;17(2):157–78.
2. Ahn WK, Proctor CC, Flanagan EH. Mental health clinicians’ beliefs about the biological, psychological, and environmental bases of mental disorders. Cogn Sci. 2009;33(2):147–82.
3. Allsopp K, Kinderman P. A proposal to introduce formal recording of psychosocial adversities associated with mental health using ICD-10 codes. Lancet Psychiatry. 2017;4(9):664–5.
4. American Psychiatric Publishing. Diagnostic and statistical manual of mental disorders, fifth edition: DSM-5. Arlington: American Psychiatric Publishing; 2013.
5. Angell M. The truth about the drug companies: how they deceive us and what to do about it. New York: Random House, Incorporated; 2005.
6. Bains J. Race, culture and psychiatry: a history of transcultural psychiatry. Hist Psychiatry. 2005;16(2):139–54.
7. Bartholomew RE. Exotic deviance: medicalizing cultural idioms – from strangeness to illness. Boulder: University Press of Colorado; 2000. Retrieved from: https://www1.bps.org.uk/system/files/Public%20files/cat-1325.pdf
8. Batstra L, Frances A. Holding the line against diagnostic inflation in psychiatry. Psychother Psychosom. 2012;81(1):5–10.
9. Bell V. Why we need to get better at critiquing psychiatric diagnosis; 2017. Available from: https://mindhacks.com/2017/09/19/why-we-need-to-get-better-at-critiquing-diagnosis/
10. Bilder R, Cuthbert B, Carpenter W, Ford J, Marder S, Hoffman R, et al., editors. The NIMH research domain criteria (RDoC) initiative: high road to rational psychiatry or barrier to current Progress? Neuropsychopharmacology. London: Nature Publishing Group; 2014. p. 39. https://www.researchgate.net/publication/279024462_The_NIMH_Research_Domain_Criteria_RDoC_Initiative_High_Road_to_Rational_Psychiatry_or_Barrier_to_Current_Progress
11. Bolton D, Hill J. Mind, meaning, and mental disorder: the nature of causal explanation in psychology and psychiatry. Oxford: Oxford University Press; 1996.
12. Borsboom D, Rhemtulla M, Cramer A, Van der Maas H, Scheffer M, Dolan C. Kinds versus continua: a review of psychometric approaches to uncover the structure of psychiatric constructs. Psychol Med. 2016;46(8):1567–79.
13. Bourque F, van der Ven E, Malla A. A meta-analysis of the risk for psychotic disorders among first-and second-generation immigrants. Psychol Med. 2011;41(5):897–910.
14. Bracken P, Thomas P, Timimi S, Asen E, Behr G, Beuster C, et al. Psychiatry beyond the current paradigm. Br J Psychiatry. 2012;201(6):430–4.
15. Bresnahan M, Begg MD, Brown A, Schaefer C, Sohler N, Insel B, et al. Race and risk of schizophrenia in a US birth cohort: another example of health disparity? Int J Epidemiol. 2007;36(4):751–8.
16. British Psychological Society. Division of clinical psychology position statement on the classification of behaviour and experience in relation to functional psychiatric diagnoses: time for a paradigm shift; 2013. Retrieved from: https://www1.bps.org.uk/system/files/Public%20files/cat-1325.pdf.
17. Bruner J. The narrative construction of reality. Crit Inq. 1991;18(1):1–21.
18. Caplan PJ. The debate about PMDD and Sarafem: suggestions for therapists. Women Ther. 2004;27(3–4):55–67.
19. Caplan PJ. They say you’re crazy: how the world’s most powerful psychiatrists decide who’s normal. Reading: Addison-Wesley/Addison Wesley Longman; 1995.
20. Carey B. Psychiatry manual drafters back down on diagnoses. The New York Times; 2012.
21. Cartwright SA. Report on the diseases and physical peculiarities of the Negro race. New Orleans Med Surg J. 1851:691–715. [Reprinted in A. C. Caplan, H. T. Engelhardt and J. J. McCartney (Eds.), (1981). Concepts of Health and Disease (pp. 305–25). Reading: Addison-Wesley]
22. Chalmers DJ. Phenomenal concepts and the explanatory gap. In: Alter T, Walter S, editors. Phenomenal concepts and phenomenal knowledge: new essays on consciousness and physicalism. Oxford: Oxford University Press; 2006. p. 167.
23. Cohen RJ, Swerdlik ME, Phillips SM. Psychological testing and assessment: an introduction to tests and measurement. Houston: Mayfield Publishing Company; 1996.
24. Compton MT, Shim RS. The social determinants of mental health. Focus. 2015;13(4):419–25.
25. Compton WM, Guze SB. The neo-Kraepelinian revolution in psychiatric diagnosis. Eur Arch Psychiatry Clin Neurosci. 1995;245(4–5):196–201.
26. Conrad P, Schneider JW. Deviance and medicalization: from badness to sickness. Philadelphia: Temple University Press; 2010.
27. Cooke A, Kinderman P. “But what about real mental illnesses?” alternatives to the disease model approach to “schizophrenia”. J Humanist Psychol. 2018;58(1):47–71.
28. Cosgrove L, Caplan P. Bias in psychiatric diagnosis. Lanham: Aronson; 2004.
29. Cosgrove L, Riddle B. Gender bias and sex distribution of mental disorders in the DSM-IV-TR. In: Cosgrove L, Caplan P, editors. Bias in psychiatric diagnosis. Lanham: Aronson; 2004. p. 127–40.
30. Cosgrove L, Krimsky S. A comparison of DSM-IV and DSM-5 panel members’ financial associations with industry: a pernicious problem persists. PLoS Med. 2012;9(3):e1001190.
31. Cosgrove L, Wheeler EE. Industry’s colonization of psychiatry: ethical and practical implications of financial conflicts of interest in the DSM-5. Fem Psychol. 2013;23(1):93–106.
32. Cosgrove L, Krimsky S, Wheeler EE, Kaitz J, Greenspan SB, DiPentima NL. Tripartite conflicts of interest and high stakes patent extensions in the DSM-5. Psychother Psychosom. 2014;83(2):106–13.
33. Cosgrove L, Karter JM. The poison in the cure: neoliberalism and contemporary movements in mental health. Theory Psychol. 2018;28(5):669–83.
34. Cosgrove L, Peters SM, Vaswani A, Karter JM. Institutional corruption in psychiatry: case analyses and solutions for reform. Soc Personal Psychol Compass. 2018:e12394.
35. Cosgrove L, Shaughnessy AF, Shaneyfelt T. When is a guideline not a guideline? The devil is in the details. BMJ Evid Based Med. 2018;23(1):33–6.
36. Crichton P, Carel H, Kidd IJ. Epistemic injustice in psychiatry. Br J Psychiatry Bull. 2017;41(2):65–70.
37. Crossley N. Not being mentally ill: social movements, system survivors and the oppositional habitus. Anthropol Med. 2004;11(2):161–80.
38. Davies J. Political pills: psychopharmaceuticals and neoliberalism as mutually supporting. In: Davies J, editor. The sedated society. Cham: Springer Nature; 2017. p. 189–225.
39. Dillon J, Hornstein GA. Hearing voices peer support groups: a powerful alternative for
people in distress. Psychosis. 2013;5(3):286–95.
40. Drescher J. Out of DSM: depathologizing homosexuality. Behav Sci. 2015;5(4):565–75.
41. Ecks S. The strange absence of things in the “culture” of the DSM-V. Can Med Assoc J. 2016;188(2):142–3.
42. Eco U. The name of the rose. New York: Random House; 2004.
43. Elkins DN. Humanistic psychology: a clinical manifesto: a critique of clinical psychology and the need for progressive alternatives. Colorado Springs: University of Rockies Press; 2009.
44. Elliott C, Abadie R. Exploiting a research underclass in phase 1 clinical trials. N Engl J Med. 2008;358(22):2316–7.
45. Esposito L, Perez FM. Neoliberalism and the commodification of mental health. Humanit Soc. 2014;38(4):414–42.
46. Fanon F. Black skin, white masks. New York: Grove Press; 2008.
47. Fassin D, Rechtman R. The empire of trauma: an inquiry into the condition of victimhood. Princeton: Princeton University Press; 2009.
48. Fava GA. The decline of pharmaceutical psychiatry and the increasing role of psychological medicine. Psychother Psychosom. 2009;78(4):220–7.
Feisthamel K, Schwartz R. Differences in mental health counselors’ diagnoses based on client race: an investigation of adjustment, childhood, and substance-related disorders. J Ment Health Couns. 2008;31(1):47–59.
50. Firmin RL, Luther L, Lysaker PH, Minor KS, Salyers MP. Stigma resistance is positively associated with psychiatric and psychosocial outcomes: a meta-analysis. Schizophr Res. 2016;175(1):118–28.
51. Fletcher EH. Uncivilizing “mental illness”: contextualizing diverse mental states and Posthuman emotional ecologies within the Icarus project. J Med Humanit. 2018;39(1):29–43.
52. Forgione FA. Diagnostic dissent: experiences of perceived misdiagnosis and stigma in persons diagnosed with schizophrenia. J Humanist Psychol. 2018; https://doi.org/10.1177/0022167818777151.
53. Foucault M. History of madness. London: Routledge; 2013.
54. Foucault M. Madness and civilization. London: Routledge; 2003.
55. Frances A. DSM-5 ‘Psychosis risk syndrome’ – far too risky. Psychology Today; 2010. https://www.psychologytoday.com/us/blog/dsm5-in-distress/201003/dsm5-psychosis-risk-syndromefar-too-risky. Accessed 17 July 2018.
56. Frances A. Psychologists start petition against DSM 5: a users’ revolt should capture APA attention. Psychology Today; 2011. https://www.psychologytoday.com/us/blog/dsm5-in-distress/201110/psychologists-start-petition-against-dsm-5. Accessed 17 July 2018.
57. Frances A. Follow the money. Huffington Post; 2012. Available from: https://www.huffingtonpost.com/allen-frances/follow-themoney_4_b_1567113.html
58. Frances A. Newsflash from APA meeting: DSM-5 has flunked its
reliability tests. Psychology Today; 2012.
https://www.psychologytoday.com/us/blog/dsm5-in-distress/201205/newsflash-apa-meeting-dsm-5-has-flunked-its-reliability-tests. Accessed 17 July 2018.
59. Frances A. DSM-5 field trials discredit the American Psychiatric Association. Huffington Post; 2012. https://www.huffingtonpost.com/allen-frances/dsm-5-field-trials-discre_b_2047621.html.
Accessed 17 July 2018.
60. Frances A. Predicting psychosis risk is pretty risky. Huffington Post; 2012. https://www.huffingtonpost.com/allen-frances/psychosis-risk_b_1289022.html. Accessed 17 July 2018.
61. Frances A. Diagnosing the DSM. New York Times; 2012. https://www.nytimes.com/2012/05/12/opinion/break-up-the-psychiatricmonopoly.html. Accessed 17 July 2018.
62. Frances A. DSM in philosophyland: curiouser and curiouser. In: Paris J, Phillips J, editors. Making the DSM-5. New York: Springer; 2013. p. 95–103.
63. Frances AJ, Widiger T. Psychiatric diagnosis: lessons from the DSM-IV past and cautions for the DSM-5 future. Annu Rev Clin Psychol. 2012;8:109–30.
64. Fricker M. Epistemic injustice: power and the ethics of knowing. Oxford: Oxford University Press; 2007.
65. Fried EI. Moving forward: how depression heterogeneity hinders progress in treatment and research. Expert Rev Neurother. 2017;17(5):423–5. https://doi.org/10.1080/14737175.2017.1307737.
66. Fried E. Open science framework; 2018. Available from: https://osf.io/rc2qb/
67. Fried EI, Epskamp S, Nesse RM, Tuerlinckx F, Borsboom D. What are ‘good’ depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a
network analysis. J Affect Disord. 2016;189:314–20.
68. Fulford KWM, Thornton T, Graham G. Oxford textbook of philosophy and psychiatry. Oxford: Oxford University Press; 2006.
69. Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012;69(3):220–9.
70. Ginat J, Kamens SR. Experiences of hospitalization in persons diagnosed with psychotic disorders: phenomenology and relationship to symptom profiles. ISPS convention, Liverpool; 2017.
71. Goicoechea J. Invoking and inscribing mental illness: a discursive analysis of diagnostic terminology in inpatient treatment planning meetings. Fem Psychol. 2013;23(1):107–18.
72. Goldacre B. Bad pharma: how drug companies mislead doctors and harm patients. London: Macmillan; 2014.
73. Gone JP. Alternative knowledges and the future of community psychology: provocations from an American Indian healing tradition. Am J Community Psychol. 2016;58(3–4):314–21.
74. Hacking I. Kinds of people: moving targets. In: ProceedingsBritish Academy, vol. 151. Oxford: Oxford University Press, Inc; 2007. p. 285–317.
https://www.britac.ac.uk/sites/default/files/
pba151p285.pdf. Accessed 17 July 2018.
75. Hacking I. Mad travelers: reflections on the reality of transient mental illnesses. Charlottesville: University of Virginia Press; 1998.
76. Hacking I. The looping effects of human kinds. In: Sperber D, Premack D, Premack AJ, editors. Symposia of the Fyssen foundation. causal cognition: a multidisciplinary debate. New York: Clarendon Press/Oxford University Press; 1995. p. 351–94.
77. Hagan LD, Guilmette TJ. DSM-5: challenging diagnostic testimony. Int J Law Psychiatry. 2015;42:128–34.
78. Hansen H, Braslow J, Rohrbaugh RMF. Cultural to structural competency – training psychiatry residents to act on social determinants of health and institutional racism. JAMA Psychiat. 2018;75(2):117–8.
79. Hartung CM, Widiger TA. Gender differences in the diagnosis of mental disorders: conclusions and controversies of the DSM–IV. Psychol Bull. 1998;123(3):260.
80. Haslam N, Holland E, Kuppens P. Categories versus dimensions in personality and psychopathology: a quantitative review of taxometric research. Psychol Med. 2012;42(5):903–20.
81. Haynes SN, Richard D, Kubany ES. Content validity in psychological assessment: a functional approach to concepts and methods. Psychol Assess. 1995;7(3):238.
82. Horwitz AV. Creating mental illness. Chicago: University of Chicago Press; 2002.
83. Houts AC. Discovery, invention, and the expansion of the modern diagnostic and statistical manuals of mental disorders. In: Beutler LE, Malik ML, editors. Decade of behavior. Rethinking the DSM: a psychological perspective. Washington, DC: American Psychological Association; 2002. p. 17–65.
84. Illich I. Medical nemesis: the expropriation of health. New York: Pantheon; 1977.
85. Illich I. The medicalization of life. J Med Ethics. 1975;1(2):73–7.
86. Insel T. Post by former NIMH director Thomas Insel: transforming diagnosis; 2013. https://www.nimh.nih.gov/about/directors/thomas-insel/blog/2013/transforming-diagnosis.shtml. Accessed 18 Nov 2016.
87. Johnson SL, Wibbels E, Wilkinson R. Economic inequality is related to cross-national prevalence of psychotic symptoms. Soc Psychiatry Psychiatr Epidemiol. 2015;50(12):1799–807.
88. Johnstone L, Boyle M, Cromby J, editors. The power/threat/meaning: framework: beyond diagnosis to meaning-based patterns in emotional distress. In: Division of clinical psychology
annual conference; 2017.
89. Johnstone L, Boyle M, with Cromby J, Dillon J, Harper D, Kinderman P, Longden E, Pilgrim D, Read J. The power threat meaning framework: overview. Leicester: British Psychological
Society; 2018.
90. Kamens S. Attenuated psychosis syndrome was not actually removed from DSM-5. DxSummit.org; 2013. Available from: http://dxsummit.org/archives/1728
91. Kamens S. Controversial issues for the future DSM-V. Society for humanistic psychology newsletter; 2010.
92. Kamens SR, Cosgrove L, Peters SM, Jones N, Flanagan E, Longden E, et al. Standards and guidelines for the development of diagnostic nomenclatures and alternatives in mental health
research and practice. J Humanist Psychol; 2018. https://doi-org.ezproxy.lib.umb.edu/10.1177/0022167818763862
93. Kamens SR, Elkins DN, Robbins BD. Open letter to the DSM-
5. J Humanist Psychol. 2017;57(6):675–87.
94. Kamens SR. On the proposed sexual and gender identity diagnoses for DSM-5: history and controversies. Humanist Psychol.
2011;39(1):37.
95. Kendler KS. A psychiatric dialogue on the mind-body problem.
Am J Psychiatr. 2001;158(7):989–1000.
96. Kendler KS. The nature of psychiatric disorders. World
Psychiatry. 2016;15(1):5–12.
97. Kendler KS. Toward a philosophical structure for psychiatry.
Am J Psychiatr. 2005;162(3):433–40.
98. Kievit RA, Romeijn J-W, Waldorp LJ, Wicherts JM, Scholte
HS, Borsboom D. Modeling mind and matter: reductionism and
psychological measurement in cognitive neuroscience. Psychol
Inq. 2011;22(2):139–57.
99. Kim NS, Ahn W-k. Clinical psychologists’ theory-based representations of mental disorders predict their diagnostic reasoning and memory. J Exp Psychol Gen. 2002;131(4):451.
100. Kirkbride JB, Jones PB, Ullrich S, Coid JW. Social deprivation,
inequality, and the neighborhood-level incidence of psychotic
syndromes in East London. Schizophr Bull. 2012;40(1):169–80.
101. Kirmayer LJ, Crafa D. What kind of science for psychiatry?
Front Hum Neurosci. 2014;8:435.
102. Kirmayer LJ. Beyond the ‘new cross-cultural psychiatry’: cultural biology, discursive psychology and the ironies of globalization. Transcult Psychiatry. 2006;43(1):126–44.
103. Kirmayer LJ. Cultural variations in the response to psychiatric disorders and emotional distress. Soc Sci Med.
1989;29(3):327–39.
104. Kirmayer LJ. Mind and body as metaphors: hidden values in
biomedicine. In: Culture, illness, and healing, vol. 13. Dordrecht:
Springer; 1998. p. 57–93.
105. Kirschner SR. Diagnosis and its discontents: critical perspectives on psychiatric nosology and the DSM. Fem Psychol.
2013;23(1):10–28.
106. Kleinman A, Good B. Culture and depression: studies in the
anthropology and cross-cultural psychiatry of affect and disorder. Berkeley: University of California Press; 1986.
107. Kotov R, Krueger RF, Watson D, Achenbach TM, Althoff RR,
Bagby RM, et al. The hierarchical taxonomy of psychopathology (HiTOP): a dimensional
alternative to traditional nosologies. J Abnorm Psychol. 2017;126(4):454.
108. Krimsky S. Science in the private interest: has the lure of profits
corrupted biomedical research. Lanham: Rowman & Littlefield;
2004.
109. Kriss S. Book of lamentations. The New Inquiry; 2013 Available
from: https://thenewinquiry.com/book-of-lamentations/
110. Kroska A, Harkness SK. Exploring the role of diagnosis in
the modified labeling theory of mental illness. Soc Psychol Q.
2008;71(2):193–208.
111. Lane C. The American Psychiatric Association’s trial balloons.
Psychology Today; 2011.
112. Lasalvia A, Penta E, Sartorius N, Henderson S. Should
the label “schizophrenia” be abandoned? Schizophr Res.
2015;162(1):276–84.
113. Lebowitz MS. Biological conceptualizations of mental disorders among affected individuals: a review of correlates and
consequences. Clin Psychol Sci Pract. 2014;21(1):67–83.
114. Lessig L. “Institutional corruption” defined. J Law Med Ethics.
2013;41(3):553–5.
115. Levine J. Materialism and qualia: the explanatory gap. Pac
Philos Q. 1983;64(4):354–61.
116. Lewis-Fernández R, Aggarwal NK, Bäärnhielm S, Rohlof
H, Kirmayer LJ, Weiss MG, Jadhav S, Hinton L, Alarcón
RD, Bhugra D, Groen S. Culture and psychiatric evaluation:
operationalizing cultural formulation for DSM-5. Psychiatry.
2014;77(2):130–54.
117. Longdon E, Read J. ‘People with problems, not patients with
Illnesses’: using psychosocial frameworks to reduce the stigma
of psychosis. Isr J Psychiatry Relat Sci. 2017;54(1):24–8.
118. Luhrmann TM, Padmavati R, Tharoor H, Osei A. Differences
in voice-hearing experiences of people with psychosis in the
USA, India and Ghana: interview-based study. Br J Psychiatry.
2015;206(1):41–4.
119. Makowski AC, Mnich EE, Ludwig J, Daubmann A, Bock T,
Lambert M, et al. Changes in beliefs and attitudes toward
people with depression and schizophrenia – results of a public
campaign in Germany. Psychiatry Res. 2016;237:271–8.
120. Marecek J, Gavey N. DSM-5 and beyond: a critical feminist
engagement with psychodiagnosis. London: Sage Publications;
2013.
121. Markon KE, Chmielewski M, Miller CJ. The reliability and
validity of discrete and continuous measures of psychopathology: a quantitative review. Psychol Bull. 2011;137(5):856.
122. McHugh MC, Chrisler JC. The wrong prescription for women:
how medicine and media create a “need” for treatments, drugs,
and surgery. Santa Barbara: Praeger; 2015, an imprint of ABCCLIO, LLC; 2015. Xvi.
123. Metzl JM, Hansen H. Structural competency and psychiatry.
JAMA Psychiat. 2018;75(2):115–6.
124. Metzl JM. The protest psychosis: how schizophrenia became a
black disease. Boston: Beacon Press; 2010.
125. Mills C. Decolonizing global mental health: the psychiatrization
of the majority world. London/New York: Routledge/Taylor &
Francis Group; 2014.
126. Miresco MJ, Kirmayer LJ. The persistence of mind-brain dualism in psychiatric reasoning about clinical scenarios. Am J
Psychiatr. 2006;163(5):913–8.
127. Moncrieff J. Neoliberalism and biopsychiatry: a marriage of
convenience. In: Cohen CI, Timimi S, editors. Liberatory psychiatry: philosophy, politics and mental health. Cambridge:
Cambridge University Press; 2008. p. 235–56.
128. Morawski J. Reflexivity. In: Encyclopedia of critical psychology.
New York: Springer; 2014.
129. Moseley DD, Gala G. Philosophy and psychiatry: problems,
intersections and new perspectives. London: Routledge;
2015.
130. Nagel T. The view from nowhere. Oxford: Oxford University
Press; 1989.
131. Nemeroff CB, Weinberger D, Rutter M, MacMillan HL, Bryant
RA, Wessely S, Stein DJ, Pariante CM, Seemüller F, Berk
M, Malhi GS. DSM-5: a collection of psychiatrist views on
the changes, controversies, and future directions. BMC Med.
2013;11(1):202.
132. Nietzsche FW. Beyond good and evil: prelude to a philosophy
of the future. In: Horstmann R-P, Norman J, editors. Cambridge
texts in the history of philosophy. Cambridge: Cambridge
University Press; 2002 [Originally published in 1886].
133. Oakland L, Berry K. “Lifting the veil”: a qualitative analysis
of experiences in hearing voices network groups. Psychosis.
2015;7(2):119–29.
134. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jönsson
B. The economic cost of brain disorders in Europe. Eur J
Neurol. 2012;19(1):155–62.
135. Parnas J, Sass LA, Zahavi D. Rediscovering psychopathology:
the epistemology and phenomenology of the psychiatric object.
Schizophr Bull. 2012;39(2):270–7.
136. Parnas J. The RDoC program: psychiatry without psyche?
World Psychiatry. 2014;13(1):46–7.
137. Patil T, Giordano J. On the ontological assumptions of the
medical model of psychiatry: philosophical considerations and
pragmatic tasks. Philos Ethics Humanit Med. 2010; https://doi.
org/10.1186/1747-5341-5-3.
138. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings
J, DeKosky S. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review)
report of the quality standards Subcommittee of the American
Academy of neurology. Neurology. 2001;56(9):1133–42.
139. Phillips J. Conclusion. In: Paris J, Phillips J, editors. Making
the DSM-5: concepts and controversies. New York: Springer;
2013.
140. Phillips J, Frances A, Cerullo MA, Chardavoyne J, Decker HS,
First MB, et al. The six most essential questions in psychiatric
diagnosis: a pluralogue part 1: conceptual and definitional
issues in psychiatric diagnosis. Philos Ethics Humanit Med.
2012;7(1):3.
141. Pilecki BC, Clegg J, McKay D. The influence of corporate and
political interests on models of illness in the evolution of the
DSM. Eur Psychiatry. 2011;26(3):194–200.
142. Probst B. Queen of the owls: metaphor and identity in psychiatric diagnosis. Soc Work Ment Health. 2015;13(3):235–51.
143. Reddy LF, Horan WP, Green MF. Revisions and refinements of
the diagnosis of schizophrenia in DSM 5. Clin Psychol Sci Pract.
2014;21(3):236–44.
144. Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto
SJ, Kuhl EA, et al. DSM-5 field trials in the United States and
Canada, part II: test-retest reliability of selected categorical
diagnoses. Am J Psychiatr. 2013;170(1):59–70.
145. Rief W, Avorn J, Barsky AJ. Medication-attributed adverse
effects in placebo groups: implications for assessment of
adverse effects. Arch Intern Med. 2006;166(2):155–60.
146. Robbins B, Karter J, Gallagher K. Big pharma (kos): the stigmatized scapegoat of medicalisation and the ethics of psychiatric
diagnosis. Psychother Sect Rev. 2015;56:84–96.
147. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatr.
1970;126(7):983–7.
148. Romme M, Escher S, Dillon J, Corstens D, Morris M. Living
with voices: 50 stories of recovery. Ross-on-Wye: PCCS books;
2009.
149. Ronson J. Bipolar kids: victims of the ‘madness industry’? New
Sci. 2003;210(2815):44–7.
150. Rose N. Neurochemical selves. Society. 2003;41(1):46–59.
151. Rüsch N, Lieb K, Bohus M, Corrigan PW. Self-stigma, empowerment, and perceived
legitimacy of discrimination among
women with mental illness. Psychiatr Serv. 2006;57(3):399–402.
152. Schoenen J, Gianni F, Schretlen L, Sobocki P. Cost estimates of
brain disorders in Belgium. Acta Neurol Belg. 2006;106(4):208.
153. Schrader S, Jones N, Shattell M. Mad pride: reflections on
sociopolitical identity and mental diversity in the context of
culturally competent psychiatric care. Issues Ment Health Nurs.
2013;34(1):62–4.
154. Schulz SL. The informed consent model of transgender care:
an alternative to the diagnosis of gender dysphoria. J Humanist
Psychol. 2018;58(1):72–92.
155. Schwartz RC, Blankenship DM. Racial disparities in psychotic
disorder diagnosis: a review of empirical literature. World J
Psychiatry. 2014;4(4):133.
156. Schwartz RC, Feisthamel KP. Disproportionate diagnosis of
mental disorders among African American versus European
American clients: implications for counseling theory, research,
and practice. J Couns Dev. 2009;87(3):295–301.
157. Scott WJ. PTSD in DSM-III: a case in the politics of diagnosis
and disease. Soc Probl. 1990;37(3):294–310.
158. Scott WJ. Vietnam veterans since the war: the politics of PTSD,
agent orange, and the national memorial. Norman: University
of Oklahoma Press; 1993.
159. Shaw C, Proctor GI. Women at the margins: a critique of the
diagnosis of borderline personality disorder. Fem Psychol.
2005;15(4):483–90.
160. Silverstein C. The implications of removing homosexuality from the DSM as a mental disorder. Arch Sex Behav.
2009;38(2):161–3.
161. Spiegel H. Nocebo: the power of suggestibility. Prev Med.
1997;26(5 Pt 1):616–21.
162. Star SL. Simplification in scientific work: an example from neuroscience research. Soc Stud Sci. 1983;13(2):205–28.
163. Stoyanov D. A linkage of mind and brain: towards translational
validity between neurobiology and psychiatry. Biomedi Rev.
2014;22:65–76.
164. Summerfield D. Cross-cultural perspectives on the medicalization of human suffering. In: Rosen G, editor. Posttraumatic
stress disorder: issues and controversies. Hoboken: John Wiley
& Sons; 2004. p. 233–45.
165. Summerfield D. How scientifically valid is the knowledge base
of global mental health? Br Med J. 2008;336(7651):992.
166. Ting RSK, Sundararajan L. Culture, cognition, and emotion in
China’s religious ethnic minorities: voices of suffering among
the Yi. Cham: Springer; 2017.
167. Szasz TS. The myth of mental illness: foundations of a theory of
personal conduct. New York: Harper & Row; 1974.
168. Tabb K. Philosophy of psychiatry after diagnostic kinds.
Synthese. 2016:1–19.
169. Thornton T. Essential philosophy of psychiatry. Oxford: Oxford
University Press; 2007.
170. Tiefer L. Female sexual dysfunction: a case study of disease
mongering and activist resistance. PLoS Med. 2006;3(4):e178.
171. Tiefer L. The selling of ‘female sexual dysfunction’. J Sex
Marital Ther. 2001;27(5):625–8.
172. Tortelli A, Errazuriz A, Croudace T, Morgan C, Murray R,
Jones P, et al. Schizophrenia and other psychotic disorders in
Caribbean-born migrants and their descendants in England:
systematic review and meta-analysis of incidence rates, 1950–
2013. Soc Psychiatry Psychiatr Epidemiol. 2015;50(7):1039–55.
173. Uher R, Payne JL, Pavlova B, Perlis RH. Major depressive disorder in DSM-5: implications for clinical practice and research
of changes from DSM-IV. Depress Anxiety. 2014;31(6):459–71.
174. Ussher JM. Clinical psychology and sexual equality: a contradiction in terms? Fem Psychol. 1991;1(1):63–8.
175. Ussher JM. Are we medicalizing women’s misery? A critical
review of women’s higher rates of reported depression. Fem
Psychol. 2010;20(1):9–35.
176. van der Steen WJ, Ho VK, Karmelk FJ. Beyond boundaries of
biomedicine: pragmatic perspectives on health and disease, vol.
4. Amsterdam: Rodopi; 2003.
177. van Os J, Krabbendam L. Can the social environment cause
schizophrenia? In: Kasper S, Papadimitriou GN, editors.
Schizophrenia. Boca Raton: CRC Press; 2004. p. 54–62.
178. van Os J. “schizophrenia” does not exist. Br Med J (Online).
2016:352. https://doi.org/10.1136/bmj.i375
179. Wakefield JC. DSM-5 proposed diagnostic criteria for sexual
paraphilias: tensions between diagnostic validity and forensic
utility. Int J Law Psychiatry. 2011;34(3):195–209.
180. Wakefield JC. DSM-5: an overview of changes and controversies. Clin Soc Work J. 2013;41(2):139–54.
181. Watters E. Crazy like us: the globalization of the American
psyche. New York: Simon and Schuster; 2010.
182. Whaley AL, Hall BN. Effects of cultural themes in psychotic symptoms on the diagnosis of schizophrenia in African
Americans. Ment Health Relig Cult. 2009;12(5):457–71.
183. Whaley AL. Ethnicity/race, paranoia, and psychiatric diagnoses:
clinician bias versus sociocultural differences. J Psychopathol
Behav Assess. 1997;19(1):1–20.
184. Whaley AL. Cultural mistrust: an important psychological construct for diagnosis and treatment of African Americans. Prof
Psychol Res Pract. 2001;32(6):555.
185. Whaley AL. The culturally-sensitive diagnostic interview research project: a study on the psychiatric misdiagnosis of African American patients. Afr Am Res Perspect.
2002;8(2):57–66.
186. Whitaker R, Cosgrove L. Psychiatry under the influence: institutional corruption, social injury, and prescriptions for reform.
New York: Springer; 2015.
187. Whitaker R. Anatomy of an epidemic: psychiatric drugs and the
astonishing rise of mental illness in America. Ethical Hum Sci
Serv. 2005;7(1):23–35.
188. Whooley O. Measuring mental disorders: the failed commensuration project of DSM-5. Soc Sci Med. 2016;166:33–40.
189. Wieczner J. Drug companies look to profit from DSM-
5: binge eating and hoarding diagnoses may lead to
new sales. MarketWatch; 2013. [updated 6/5/2013].
Available from: https://www.marketwatch.com/story/
new-psych-manual-could-create-drug-windfalls-2013-06-05
190. Wilson M. DSM-III and the transformation of American psychiatry: a history. Am J Psychiatr. 1993;150:399–410.
191. Wittchen H-U, Jacobi F, Rehm J, Gustavsson A, Svensson
M, Jönsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur
Neuropsychopharmacol. 2011;21(9):655–79.
192. Yalom I. The gift of therapy. London: Piatkus; 2010.
193. Young A. The harmony of illusions: inventing post-traumatic
stress disorder. Princeton: Princeton University Press; 1997.
194. Zachar P. A metaphysics of psychopathology. Cambridge, MA:
MIT Press; 2014.
195. Zachar P, Kendler KS. A diagnostic and statistical manual of
mental disorders history of premenstrual dysphoric disorder. J
Nerv Ment Dis. 2014;202(4):346–52.